← Leaderboards
Austin Stratton Draycott
Yale University
$538,274
Attributed
$538,274
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $400K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$538,274 · 2
By mechanism
R42$399,966 · 1
F31$138,308 · 1
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- Mario Sznol$1,336,404
- Rebecca G Wells$15,805,994
- Aurora Esquela Kerscher$1,035,873
- Yong Zhu$3,989,813
- Karla M Neugebauer$9,540,425
Others in their field
Other Emerging Leaders on “Cancer Type”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$57,434,139
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Karen Martier · Westat, Inc.$35,207,008
- Greg Yothers · University Of Chicago$35,003,821
- Dwayne Forquer · Leidos Biomedical Research, Inc.$29,410,041
- Phd, Stephen Schwartz · Fred Hutchinson Cancer Research Center$21,360,715
Research focus
Cancer TypeCellsExperimental StudyOverexpressionEnzymesPseudouridineMalignant NeoplasmsTransfer RnaGenome-WideCharacteristicsEpitranscriptomeBorohydridesBehaviorFallsGenomicsDepositionCell LineBiotinDetectionCell PhysiologyBaseComplexAffectConventional (Clear Cell) Renal Cell Carcinoma
Grant awards (4)
Developing engineered inhibitors of tRNA modifying enzymes$399,966
R42 · FY2025 · CA · contact PI
Developing Tools to Map and Quantify Dihydrouridine in the Mammalian Transcriptome$46,752
F31 · FY2022 · CA · contact PI
Developing Tools to Map and Quantify Dihydrouridine in the Mammalian Transcriptome$46,036
F31 · FY2021 · CA · contact PI
Developing Tools to Map and Quantify Dihydrouridine in the Mammalian Transcriptome$45,520
F31 · FY2020 · CA · contact PI